Medpace Holdings Inc (MEDP)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	404,386	365,666	339,790	312,507	282,810	273,182	268,659	256,951	245,368	226,732	209,279	199,853	181,848	182,680	175,566	159,736	145,384	124,331	106,848	110,199
Total assets	US$ in thousands	2,100,870	2,084,060	1,920,050	1,795,790	1,656,830	1,486,720	1,406,940	1,395,720	1,352,500	1,328,420	1,315,450	1,344,350	1,659,940	1,577,140	1,469,710	1,451,360	1,390,680	1,296,140	1,222,130	1,137,630
ROA		19.25%	17.55%	17.70%	17.40%	17.07%	18.37%	19.10%	18.41%	18.14%	17.07%	15.91%	14.87%	10.96%	11.58%	11.95%	11.01%	10.45%	9.59%	8.74%	9.69%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $404,386K ÷ $2,100,870K
= 19.25%

The return on assets (ROA) for Medpace Holdings Inc has shown a generally positive trend over the provided periods, indicating the company's ability to generate profits relative to its total assets.

Starting at 9.69% on March 31, 2020, the ROA saw fluctuations but mostly displayed an upward trajectory, reaching a peak of 19.25% by December 31, 2024. This increase suggests that the company has been effectively utilizing its assets to generate earnings and create value for its investors.

The ROA figures above the industry average indicate that Medpace Holdings Inc is efficiently using its assets to generate profits. However, it is essential to consider other financial metrics and industry benchmarks to get a complete picture of the company's financial performance and efficiency.